Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

Cortellini A;Di Maio M;Nigro O;Leonetti A;Cortinovis DL;Aerts JG;Guaitoli G;Barbieri F;Giusti R;Ferrara MG;Bria E;D'Argento E;Grossi F;Rijavec E;Guida A;Berardi R;Torniai M;Sforza V;Genova C;Mazzoni F;Garassino MC;De Toma A;Signorelli D;Gelibter A;Siringo M;Marchetti P;Macerelli M;Rastelli F;Chiari R;Rocco D;Della Gravara L;Inno A;Michele T;Grassadonia A;Di Marino P;Mansueto G;Zoratto F;Filetti M;Santini D;Citarella F;Russano M;Cantini L;Tuzi A;Bordi P;Minuti G;Landi L;Ricciardi S;Migliorino MR;Passiglia F;Bironzo P;Metro G;Adamo V;Russo A;Spinelli GP;Banna GL;Friedlaender A;Addeo A;Cannita K;Ficorella C;Porzio G;Pinato DJ.

2021-01-01